Cargando…

Adjuvant therapy for high-risk melanoma

Detalles Bibliográficos
Autor principal: Eggermont, Alexander M.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041312/
https://www.ncbi.nlm.nih.gov/pubmed/26217119
http://dx.doi.org/10.1016/j.ejcsup.2013.07.014
_version_ 1782318658962325504
author Eggermont, Alexander M.M.
author_facet Eggermont, Alexander M.M.
author_sort Eggermont, Alexander M.M.
collection PubMed
description
format Online
Article
Text
id pubmed-4041312
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-40413122014-12-04 Adjuvant therapy for high-risk melanoma Eggermont, Alexander M.M. EJC Suppl Article Elsevier 2013-09 2013-10-05 /pmc/articles/PMC4041312/ /pubmed/26217119 http://dx.doi.org/10.1016/j.ejcsup.2013.07.014 Text en Copyright © 2013 ECCO - the European CanCer Organisation. All rights reserved. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Article
Eggermont, Alexander M.M.
Adjuvant therapy for high-risk melanoma
title Adjuvant therapy for high-risk melanoma
title_full Adjuvant therapy for high-risk melanoma
title_fullStr Adjuvant therapy for high-risk melanoma
title_full_unstemmed Adjuvant therapy for high-risk melanoma
title_short Adjuvant therapy for high-risk melanoma
title_sort adjuvant therapy for high-risk melanoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041312/
https://www.ncbi.nlm.nih.gov/pubmed/26217119
http://dx.doi.org/10.1016/j.ejcsup.2013.07.014
work_keys_str_mv AT eggermontalexandermm adjuvanttherapyforhighriskmelanoma